RT @GuyattGH: An early #guideline on #COVID before the #randomizedtrials came in shows how a rapidly produced guideline when evidence is li…
RT @GuyattGH: An early #guideline on #COVID before the #randomizedtrials came in shows how a rapidly produced guideline when evidence is li…
RT @GuyattGH: An early #guideline on #COVID before the #randomizedtrials came in shows how a rapidly produced guideline when evidence is li…
RT @GuyattGH: An early #guideline on #COVID before the #randomizedtrials came in shows how a rapidly produced guideline when evidence is li…
An early #guideline on #COVID before the #randomizedtrials came in shows how a rapidly produced guideline when evidence is limited can provide direction – and primarily ensure caution against indiscriminate use of unproven therapies. https://t.co/DqTYMSWGD
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis https://t.co/tEJqBUH8DM
Agree evidence quality not high, but needs close look at it before planning RCT when reported mortality OR 1.7 (n>8000) (https://t.co/tQSPAZqhtg). See recent tweet: steroids may cause benefit/harm, depending on patient: planned RCT should identify rou
@pedro77339 @MrsCurlyBot Que el acetaminofen no es ESPECÍFICO para el Covid-19, sino SINTOMÁTICO. Los únicos tratamientos específicos con evidencia clínica son dexametasona https://t.co/owL8tM872y (cuarto párrafo), https://t.co/wJStowSMkl; y el remdesivir
@respandsleepjc Biological plausibility also lent by consistency with indirect evidence from steroids for ARDS in other contexts #rsjc https://t.co/ONY7GhqJsU
RT @RevistaMFSamfyc: ...la neumonía adquirida en la comunidad y el síndrome de distrés respiratorio agudo: revisión sistemática y metaanáli…
RT @RevistaMFSamfyc: Eficacia y seguridad de los corticoides en la COVID-19 basadas en la evidencia en la COVID-19, en otras infecciones po…
...la neumonía adquirida en la comunidad y el síndrome de distrés respiratorio agudo: revisión sistemática y metaanálisis https://t.co/TmsGfrDkXk PMID 32409522
Eficacia y seguridad de los corticoides en la COVID-19 basadas en la evidencia en la COVID-19, en otras infecciones por coronavirus, la gripe,... https://t.co/TmsGfrDkXk PMID 32409522
RT @gul_kalra: @AMSA_INDIA Hi #MedTwitter 1. I am Gul, a third year medical student #MS3 2. Recent studies are discussing use of corticost…
@AMSA_INDIA Hi #MedTwitter 1. I am Gul, a third year medical student #MS3 2. Recent studies are discussing use of corticosteroids in Covid-19 https://t.co/nL8SYUYUBq 3. @Preeyati_99 @PeerLeahSarah @zohaasghar16 @ayahkarraaly @DesaiAleena
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis. https://t.co/hzSnqJcXrK
New2Trip: Efficacy & safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia & acute respiratory distress syndrome: systematic review & meta-analysis https://t.
RT @rincondesisifo: (CMAJ) Seguridad y eficacia de los corticoides en #COVID19 en base a la evidencia en pac con COVID19, otras infecciones…
RT @tripdatabase: New2Trip: Efficacy & safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections,…
RT @tripdatabase: New2Trip: Efficacy & safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections,…
New2Trip: Efficacy & safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia & acute respiratory distress syndrome: systematic review & meta-analysis https://t.
RT @jesusmendezzz: V. Prasad (@VPrasadMDMPH): La COVID-19 puede haber despertado una mística clínica, la sensación de que es algo tan inusu…
RT @rincondesisifo: (CMAJ) Seguridad y eficacia de los corticoides en #COVID19 en base a la evidencia en pac con COVID19, otras infecciones…
RT @rincondesisifo: (CMAJ) Seguridad y eficacia de los corticoides en #COVID19 en base a la evidencia en pac con COVID19, otras infecciones…
RT @rincondesisifo: (CMAJ) Seguridad y eficacia de los corticoides en #COVID19 en base a la evidencia en pac con COVID19, otras infecciones…
RT @rincondesisifo: (CMAJ) Seguridad y eficacia de los corticoides en #COVID19 en base a la evidencia en pac con COVID19, otras infecciones…
RT @rincondesisifo: (CMAJ) Seguridad y eficacia de los corticoides en #COVID19 en base a la evidencia en pac con COVID19, otras infecciones…
RT @rincondesisifo: (CMAJ) Seguridad y eficacia de los corticoides en #COVID19 en base a la evidencia en pac con COVID19, otras infecciones…
RT @rincondesisifo: (CMAJ) Seguridad y eficacia de los corticoides en #COVID19 en base a la evidencia en pac con COVID19, otras infecciones…
@mafanavarrete
(CMAJ) Eficacia y seguridad de los corticosteroides en COVID-19 según la evidencia de COVID-19, otras infecciones por coronavirus, gripe, neumonía adquirida en la comunidad y síndrome de distrés respiratorio agudo: una revisión sistemática y metanálisis ht
(CMAJ) Seguridad y eficacia de los corticoides en #COVID19 en base a la evidencia en pac con COVID19, otras infecciones por Coronavirus, gripe, NAC y SDRA https://t.co/Fkw0755YR0 Rev Sist y MA https://t.co/5DVdRGjQdl
RT @tripdatabase: New2Trip: Efficacy & safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections,…
New2Trip: Efficacy & safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia & acute respiratory distress syndrome: systematic review & meta-analysis https://t.
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @DrSamuelBrown: Some insights into the muddy priors for steroids in COVID19. https://t.co/u7yGM1j8hT I do think we're going to have to a…
RT @tripdatabase: New2Trip: Efficacy & safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections,…
New2Trip: Efficacy & safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia & acute respiratory distress syndrome: systematic review & meta-analysis https://t.
@platushka @medpedshosp It is right. However, the evidence from the corticosteroid studies in SARS and MERS is observational and only 1 RCT (evaluated with very low quality of evidence). Please look at this systematic review 👉🏼 https://t.co/dH3eTAxmpK
RT @jesusmendezzz: V. Prasad (@VPrasadMDMPH): La COVID-19 puede haber despertado una mística clínica, la sensación de que es algo tan inusu…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
@nicolesandler New off label covid19 drug is dexamethasone https://t.co/B3dHg0NbMo with promise in ppl with worst breathing difficulty.
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
Since when has it become OK to release new results through media before proper peer review publication?
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @jesusmendezzz: V. Prasad (@VPrasadMDMPH): La COVID-19 puede haber despertado una mística clínica, la sensación de que es algo tan inusu…
V. Prasad (@VPrasadMDMPH): La COVID-19 puede haber despertado una mística clínica, la sensación de que es algo tan inusual que requiere abordajes muy diferentes a los acostumbrados. Y eso puede ir en contra de algunas prácticas basadas en la evidencia. htt
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @chuletadeosler: Esto cambiará? Post del 19 d mayo jeje
Esto cambiará? Post del 19 d mayo jeje
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @VatsalTrivediMD: @iwashyna How about this: https://t.co/XNWArAEhuy Cc: @Bram_Rochwerg
RT @VatsalTrivediMD: @iwashyna How about this: https://t.co/XNWArAEhuy Cc: @Bram_Rochwerg
Some insights into the muddy priors for steroids in COVID19. https://t.co/u7yGM1j8hT I do think we're going to have to adjust our GRADE standards to make sense of pragmatic open label trials. Where, exactly, do they fit in the landscape of actionable medic
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @VatsalTrivediMD: @iwashyna How about this: https://t.co/XNWArAEhuy Cc: @Bram_Rochwerg
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
@iwashyna How about this: https://t.co/XNWArAEhuy Cc: @Bram_Rochwerg
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
@estarianne @DavidJuurlink I read that study. Older studies were not quite so high on the use of steroids. Here's another one: https://t.co/APb6MLYZp6
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…
RT @Bram_Rochwerg: Media report of RECOVERY suggests Dexamethasone reduces mortality in vented COVID pts [RR 0.65 (95% CI 0.48 to 0.88)].…